Percentage of U.S. Population that Is Overweight, 1976-2004TriMark PublicationsDecember 15, 2008 SKU: TRI2056412 |
|
Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018
2/29/2012 | published by: GlobalData
Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source
|
more...
|
$3,995.00
|
|
Health on the Restaurant Menu: Foodservice Trends in the U.S.
12/1/2011 | published by: Packaged Facts
Health on the Restaurant Menu: Foodservice Trends in the U.S. helps foodservice industry participants align their branding and menu development strategies with evolving consumer health perceptions and expectations; the quickly evolving health education landscape; and
|
more...
|
$3,995.00
|
|
World Market for Gastrointestinal Devices (Rigid, Flexible and Capsule Endoscopes, Bariatric Surgery, Ostomy Products, Enteral Feeding Pumps and Other Devices)
1/1/2012 | published by: Kalorama Information
This report, The World Market for Gastrointestinal Devices , details the market for endoscopes and other devices used for treating gastrointestinal conditions. There are many factors behind the growth of this market. Cancer
|
more...
|
$3,500.00
|
|
Obesity – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Obesity – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Obesity - Pipeline Review, H1 2012', provides an overview of the Obesity therapeutic pipeline. This report provides information on the therapeutic development for Obesity, complete with latest
|
more...
|
$500.00
|
|
Global Obesity Drug Market Analysis
6/1/2011 | published by: RNCOS
The obesity epidemic has been disseminating among developed countries as well as low-income and middle-income countries. The main factor responsible for the propagation of this disease in the middle and low income countries is the
|
more...
|
$1,000.00
|
|
Hot Topics: Obesity - The US FDA and cardiovascular risk analysis: the AdComm Cometh
7/27/2011 | published by: Datamonitor
Introduction Datamonitor proposes that the guidelines for developing obesity therapeutics are going to be overhauled in 2012, with major repercussions for developers. Trial requirements are likely to intensify substantially, the prospect of which has already pushed
|
more...
|
$3,800.00
|
|
Obesity - Pipeline Review, H2 2011
9/28/2011 | published by: Global Markets Direct
Obesity - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Obesity - Pipeline Review, H2 2011', provides an overview of the Obesity therapeutic pipeline. This report provides information on the therapeutic development for Obesity, complete with latest
|
more...
|
$500.00
|
|
Understanding Weight Management in 2011 and Beyond
10/11/2011 | published by: Euromonitor International
The obesity epidemic is placing a financial burden on governments, employers, health practitioners and individuals. As unhealthy foods and beverages increase sales, people find it harder to fight cravings and control their weight. Finding a
|
more...
|
$2,000.00
|
|
UAE Healthcare Sector Forecast to 2012
11/1/2011 | published by: RNCOS
The UAE healthcare industry has shown an unprecedented growth over the past few years and is expected to continue growing in the future as well on the back of increasing population, rising prevalence of lifestyle
|
more...
|
$1,000.00
|
|
Health And Wellness In Australia
11/2/2011 | published by: Euromonitor International
The high prevalence of obesity, diabetes and other health problems remain a serious social problem in Australia and this continued to increase the awareness about the importance of health and diet. This resulted in an
|
more...
|
$1,900.00
|
Related Markets
Obesity Reports
- Anti-Obesity Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Anti-Obesity Drugs
- Hot Topics: Obesity - Three Complete Response Letters and one Advisory Committee meeting
- Hot Topics: Obesity - The US FDA and cardiovascular risk analysis: the AdComm Cometh
- Product Profiles: Obesity - Pipeline stalls as regulatory requirements escalate
